Beihai Gofar Chuanshan Biological Co (SHSE:600538) Cyclically Adjusted Revenue per Share: ¥ (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600538 Beihai Gofar Chuanshan Biological Co Ltd SHSE:600538
57 GF Score
Price ¥4.90
GF Value ¥4.66
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Beihai Gofar Chuanshan Biological Co Cyclically Adjusted Revenue per Share?

Beihai Gofar Chuanshan Biological Co SHSE:600538 -0.20% 57 Cyclically Adjusted Revenue per Share is ¥ as of Jun. 2026. GuruFocus rates SHSE:600538 with a GF Score™ of 57/100 and a GF Value™ of ¥4.66 (Fairly Valued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Beihai Gofar Chuanshan Biological Co's adjusted revenue per share for the three months ended in Jun. 2026 was ¥0.147. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ¥ for the trailing ten years ended in Jun. 2026.

During the past 12 months, Beihai Gofar Chuanshan Biological Co's average Cyclically Adjusted Revenue Growth Rate was -5.90% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was -8.70% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was -10.00% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was -7.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Beihai Gofar Chuanshan Biological Co was 3.90% per year. The lowest was -11.40% per year. And the median was -6.30% per year.

As of today (2026-09-22), Beihai Gofar Chuanshan Biological Co's current stock price is ¥4.90. Beihai Gofar Chuanshan Biological Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was ¥. Beihai Gofar Chuanshan Biological Co's Cyclically Adjusted PS Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Beihai Gofar Chuanshan Biological Co was 8.87. The lowest was 2.20. And the median was 4.44.


Beihai Gofar Chuanshan Biological Co  (SHSE:600538) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Beihai Gofar Chuanshan Biological Co was 8.87. The lowest was 2.20. And the median was 4.44.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Beihai Gofar Chuanshan Biological Co Cyclically Adjusted Revenue per Share Related Terms


Beihai Gofar Chuanshan Biological Co Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Beihai Gofar Chuanshan Biological Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beihai Gofar Chuanshan Biological Co Cyclically Adjusted Revenue per Share Chart

Beihai Gofar Chuanshan Biological Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Beihai Gofar Chuanshan Biological Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

SHSE:600538 vs CTVA, CF, MOS: Cyclically Adjusted Revenue per Share Comparison

For the Agricultural Inputs subindustry, Beihai Gofar Chuanshan Biological Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beihai Gofar Chuanshan Biological Co Cyclically Adjusted PS Ratio vs Agriculture Industry

For the Agriculture industry and Basic Materials sector, Beihai Gofar Chuanshan Biological Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Beihai Gofar Chuanshan Biological Co's Cyclically Adjusted PS Ratio falls into.


SHSE:600538
57GF Score
Beihai Gofar Chuanshan Biological Co Ltd SHSE:600538
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Beihai Gofar Chuanshan Biological Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Beihai Gofar Chuanshan Biological Co's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.147/116.0564*116.0564
=0.147

Current CPI (Jun. 2026) = 116.0564.

Beihai Gofar Chuanshan Biological Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 0.210 102.400 0.238
201612 0.271 102.600 0.307
201703 0.231 103.200 0.260
201706 0.172 103.100 0.194
201709 0.257 104.100 0.287
201712 0.276 104.500 0.307
201803 0.105 105.300 0.116
201806 0.115 104.900 0.127
201809 0.129 106.600 0.140
201812 0.133 106.500 0.145
201903 0.120 107.700 0.129
201906 0.121 107.700 0.130
201909 0.153 109.800 0.162
201912 0.147 111.200 0.153
202003 0.127 112.300 0.131
202006 0.126 110.400 0.132
202009 0.138 111.700 0.143
202012 0.178 111.500 0.185
202103 0.184 112.662 0.190
202106 0.188 111.769 0.195
202109 0.218 112.215 0.225
202112 0.227 113.108 0.233
202203 0.231 114.335 0.234
202206 0.188 114.558 0.190
202209 0.227 115.339 0.228
202212 0.229 115.116 0.231
202303 0.192 115.116 0.194
202306 0.177 114.558 0.179
202309 0.170 115.339 0.171
202312 0.162 114.781 0.164
202403 0.166 115.227 0.167
202406 0.168 114.781 0.170
202409 0.165 115.785 0.165
202412 0.147 114.893 0.148
202503 0.149 115.116 0.150
202506 0.143 114.907 0.144
202509 0.163 115.471 0.164
202512 0.170 115.832 0.170
202603 0.158 116.303 0.158
202606 0.147 116.056 0.147

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ¥ mean?
Beihai Gofar Chuanshan Biological Co (SHSE:600538) has a Cyclically Adjusted Revenue per Share of ¥ as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Beihai Gofar Chuanshan Biological Co and its competitors.
Is Beihai Gofar Chuanshan Biological Co's Cyclically Adjusted Revenue per Share too high?
Beihai Gofar Chuanshan Biological Co's current Cyclically Adjusted Revenue per Share is ¥. Overall, Beihai Gofar Chuanshan Biological Co has a GF Score™ of 57/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Beihai Gofar Chuanshan Biological Co's Cyclically Adjusted Revenue per Share compare to CTVA and CF?
Beihai Gofar Chuanshan Biological Co's Cyclically Adjusted Revenue per Share of ¥ can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for an Agriculture company?
A good Cyclically Adjusted Revenue per Share depends on the Agriculture industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Beihai Gofar Chuanshan Biological Co and its competitors. Beihai Gofar Chuanshan Biological Co's current Cyclically Adjusted Revenue per Share is ¥. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beihai Gofar Chuanshan Biological Co stock overvalued right now?
Based on GuruFocus' analysis, Beihai Gofar Chuanshan Biological Co (SHSE:600538) is currently considered Fairly Valued. The stock's GF Value™ is ¥4.66, compared to a current price of ¥4.90 — trading 5.2% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is ¥. Beihai Gofar Chuanshan Biological Co's overall GF Score™ is 57/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Beihai Gofar Chuanshan Biological Co (SHSE:600538), the current Cyclically Adjusted Revenue per Share is ¥ as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Beihai Gofar Chuanshan Biological Co (SHSE:600538) Overvalued in 2026?

Based on GuruFocus' analysis, Beihai Gofar Chuanshan Biological Co stock appears to be overvalued. The current stock price of ¥4.90 is trading 5.2% above its estimated GF Value™ of ¥4.66. GuruFocus considers Beihai Gofar Chuanshan Biological Co to be Fairly Valued.

Key valuation signals for SHSE:600538:

  • Cyclically Adjusted Revenue per Share: ¥
  • GF Value™: ¥4.66 vs. price of ¥4.90 (5.2% above fair value)
  • GF Score™: 57/100 with 3 warning signs

No single metric tells the full story. See the SHSE:600538 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Beihai Gofar Chuanshan Biological Co Business Description

Address No. 3, Beibuwan Middle Road, Guangxi Zhuang Autonomous Region, Beihai, Guangxi, CHN, 536000
Beihai Gofar Chuanshan Biological Co Ltd main business include pharmaceutical manufacturing and pharmaceutical distribution industry, judicial IVD (in vitro diagnostic) technology services, molecular medical imaging centers and tumor radiotherapy centers and tumor telemedicine technology services, etc.
57GF Score

Get the complete analysis for SHSE:600538

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥4.90
Price
¥4.66
GF Value